Enveda Raises $311 Million to Advance AI-Powered Drug Discovery
Enveda Raises $311 Million From Leading AI and Biotech Investors to Bring Pharma Into the 21st Century Enveda, a clinical-stage biotechnology company that uses AI to discover medicines from life’s chemistry, announced the close of a $311 million Series E…
Refrigeration Technologies Launches Viper Drainado 15-in-1 Tool for HVACR and Plumbing Drain Lines
Refrigeration Technologies Introduces Viper Drainado 15-in-1 Tool for HVACR Condensate Lines and Plumbing Drains Refrigeration Technologies, the Southern California-based manufacturer behind the Viper® line of non-toxic HVACR chemical solutions, today announced the launch of Viper Drainado™, a 15-in-1 adapter that…
Kincell Bio and Cellipont Bioservices Merge to Create Kincellis Advanced Therapies
Kincell Bio and Cellipont Bioservices Merge to Form Kincellis Advanced Therapies Kincell Bio and Cellipont Bioservices announced the completion of their merger to form Kincellis Advanced Therapies a U.S.-based contract development and manufacturing organization focused on cell therapies and other…
Merz Therapeutics Secures EU/EEA Approval for XEOMIN® to Treat Pediatric Spasticity Linked to Pes Equinus
Merz Therapeutics Receives EU/EEA Approval for XEOMIN® for the Treatment of Pediatric Spasticity Associated With Pes Equinus Merz Therapeutics, a leading player in neurology-focused specialty pharma, announced that it has received approval in the European Union (EU) / European Economic…
AESARA Names Denise Sánchez as Vice President of Regulatory Counsel and Compliance
AESARA Appoints Denise Sánchez as Vice President, Regulatory Counsel & Compliance Strategies AESARA, a leading Value & Access agency, announced that Denise Sánchez, JD, MS, MA, has joined the company as Vice President, Regulatory Counsel & Compliance Strategies. She served…
HealthCap Invests in AMRA Medical to Drive Global Quantitative MRI Growth
HealthCap Invests in AMRA Medical to Accelerate Global Growth in Quantitative MRI AMRA Medical announced an investment from HealthCap, one of Europe’s leading life science venture capital firms. This milestone marks a significant step in AMRA’s growth, underscoring market confidence in the…
Infleqtion Advances Fault-Tolerant Quantum Computing with NVIDIA CUDA-Q Logical
Infleqtion Advances Fault-Tolerant Quantum Computing Software with NVIDIA CUDA-Q Logical Infleqtion a global leader in quantum computing and quantum sensing powered by neutral-atom technology, announced results from its integration of NVIDIA CUDA-Q Logical with the qLDPC open-source library for quantum…
Vyriad Launches Phase 1 Trial of VV169 In Vivo CAR T Cell Therapy After FDA IND Clearance
Vyriad Begins Phase 1 Clinical Trial for Lead In Vivo CAR T Cell Therapy VV169 Following FDA Acceptance of IND Application Vyriad, Inc., a clinical-stage biotechnology company developing targeted genetic therapies for cancer and other serious diseases, today announced that…
IMCD to Present Innovative Formulation Concepts and Sensory Solutions at In-Cosmetics Latin America 2026
IMCD to showcase formulation concepts and sensory experience at In-Cosmetics Latin America 2026 IMCD Group a leading global partner for the distribution and formulation of speciality chemicals and ingredients, will be exhibiting at In-Cosmetics Latin America 2026, on 23 and…
Indianapolis Community Unites to Take Action Against Breast Cancer at Susan G. Komen® MORE THAN PINK Walk
Breast Cancer Continues to Impact Communities; Indianapolis Rallies Together to Take Action at the Susan G. Komen® MORE THAN PINK Walk Susan G. Komen®, the world’s leading breast cancer organization, announced it will host the Indianapolis MORE THAN PINK Walk bringing together…
Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems for High-Sensitivity MRD Testing
Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, announced that commercial shipments of the PrepQuant™ System have begun in North America. First…
Cleerly Links AI-QCT Plaque Measurements to Long-Term Cardiovascular Risk
Cleerly Announces New Findings on How AI-QCT Plaque Measurements Relate to Long-Term Cardiovascular Risk Cleerly, a leader in advanced cardiovascular imaging analysis, announced findings from a study of 1,385 patients with suspected coronary artery disease (CAD) presented at the European…